Vasculitis Flashcards
GCA treatment
Visual threatening
Visual non-threatening
Visual threatening - IV methylprednisolone 500-1000mg 3/7
Visual non-threatening - PO prednisolone 50mg
Start ASAP while working up patient
Adjunct
- PPI for gastric protection
- Calcium, vitamin D
- Low dose aspirin for increased CV and CVA events
GCA affects what sized arteries?
Medium to large vessel vasculitis of the elderly
5 cardinal symptoms GCA
Headache
Jaw claudication (after 1 min of chewing)
Vision disturbance (mononuclear)
Constitutional upset - weight loss, night sweats, fever
PMR - hip, shoulder girdle inflammatory pain
96% have elevated CRP or ESR
GCA affects which vessels?
Superficial cranial arteries (vision loss)
Aorta
Aortic branches, subclavian, axillary - UL claudication symptoms
Diagnosis of GCA
Temporal artery biopsy (gold standard)
- Up to 2 weeks post steroid
- False negative in 20% of patients (skip lesions or not affect the temporal artery at all)
- Do both sides
Others
PET/CT angiogram
- Within 2-4 days of starting steroids
- Useful for large vessel vasculitis
Vascular USS
- Within 2-4 days of starting steroids
- Superficial temporal artery and axillary arteries
- Halo sign (wall thickening)
High resolution MRI with GAD
If PET/CT scan and vascular USS are floridly positive for GCA, then technically don’t need temporal artery biopsy (but in reality we do, for PBS approval)
Tocilizumab (IL6 blocker) in GCA
What’s the evidence? When is it used?
Historically, we do 12-24 months prednisolone wean. ~50% relapse rate.
Tocilizumab reduces rate of relapse when added to prednisolone (20% vs 50%)
Used in conjunction with pred to reduce duration of pred (only need to give 6/12 of pred)
*Particularly useful in OP, diabetes, steroid SEs (where we want to avoid long pred use)
PBS approves only 12 months
Note when we stop tocilizumab, we do see flare in GCA
3 vascular complications of GCA
1) permanent vision loss in >25% untreated patients
- Anterior ischaemic optic neuropathy
2) aortic aneurysm and dissection
3) peripheral and CVA
- Stroke
- Limb claudication
Presentation of Takayasu arteritis
Limb claudication Reduced/absent pulse in the upper extremity Differential limb SBP >10mmHg Aortic/subclavian artery bruit All from arteritis --> vessel narrowing
Fever, night sweats, weight loss
Asian female <40
Elevated inflammatory markers, negative autoimmune serology
Rx takayasu arteritis
Steroids +/- TNFi, MTX, lefluonamide, tocilizumab (IL6 blocker)
Polyarteritis nodosa presentation
Constitutional symptoms
Affects MANY organs (organ ischaemia/infarction) except lungs
- Hypertension, renal failure (renal artery)
- Abdo pain with melena (mesenteric artery)
- Neurological sx
- Peripheral neuropathy (nerves supplied by medium vessels)
- Painful, ulcerating rash
- Limb claudication
- ACS
- Orchitis
Very rare
Elevated inflammatory markers
NEGATIVE autoimmune serology (neg ANCA)
Associated with hep B, hep C
Diagnosis polyarteritis nodosa
Biopsy: skin, nerve/muscle, kidney (necrosis)
CT or MR angiogram: distal mesenteric and intrarenal aneurysm
Angiogram is gold standard
Has a string of pearls appearance due to healing with fibrosis (Dont confuse with fibromuscular dysplasia!)
6 groups of small vessel vasculitis
1) ANCA: GPA, MPA, EGPA
2) CTD related: RA, SLE, Sjorens
3) Other immune complex: HSP (IgA), cryoglobulin
4) Infection: Hep B, C, HIV, bacterial (e.g. strep/staph)
5) Drug induced
- Cocaine
- PTU, hydralazine, allopurinol, sulphasalazine, frusemide, minocycline, ciprofloxacin, clozapine
- P-ANCA +, high MPO
6) Malignancy: haematological most common
And some are idiopathic
Clinical features of small vessel vasculitis
Constitutional upset: fever, weight loss, sweats
Skin: palpable purpura
Joints: non erosive inflammatory arthritis
Nerves: painful multifocal peripheral neuropathy (foot drop, wrist drop)
ENT: bloody nasal DC, daily crusting, bony destruction on CT (cocaine, GPA, invasive fungal sinus disease)
Kidneys: active urine sediment, hypertension, creatinine
Lungs: alveolar haemorrhage, lung masses
Eyes: scleritis, orbital masses
Palpable purpura (leukocytoclastic vasculitis)
Pathophysiology
Biopsy findings
Capillary wall inflammation –> extravasation of blood products and inflammatory cell debris
3 features on biopsy
- Fibrinoid necrosis (fibrin in wall)
- Neutrophil dust - leukocytoclastic
- Extravasated RBCs
If positive IgA staining = IgA vasculitis (HSP)
Clinical features of palpable purpura
Dependent
Purpuric, non-blanching (red cell extravasation)
Palpable/elevated (inflammatory cells in skin)
Painless (unless deeper vessels involved)
- Think deeper vessels (polyarteritis nodosa; medium sized vasculitis) if painful/ulcerative
Small vessel vasculitis workup
ANCA
- ANCA (MPO, PR3), GBM (if renal, lung)
CT disease panel
- ANA, ENA, dsDNA, C3, C4, RF, CCP
Infection
- Hep B, C, HIV, strep serology, BCs
Cryoglobulinaemia
- Cryoglobulin
Malignancy
- FBC +/- SPEP
Everyone
- Urine microscopy and ACR
- FBC, CRP, ESR, UEC, LFTs
ANCA associated vasculitis (3 types)
All small vessel vasculitis
1) Granulomatosis with polyangiitis (GPA)
- c-ANCA, PR3+
2) Microscopic polyangiitis (MPA)
- p-ANCA, MPO+
3) Eosinophilic granulomatosis with polyangiitis (EGPA)
- p-ANCA, MPO+
Treatment GPA and MPA with major organ involvement (kidney, lung, nerve)
Induction (6 months)
- Rituximab
- Low dose steroid
- No role for routine plasmapheresis
Maintenance (4 years+)
- Rituximab
Treatment GPA and MPA with minor organ involvement e.g. palpable purpura, some sinus disease
Induction: MTX + steroid
Maintenance: MTX or azathioprine
Treatment of EGPA major organ involvement (cardiac, renal, CNS, GIT)
Induction
- Rituximab
- Steroid
Maintenance
- Azathioprine or MTX
Treatment of EGPA minor organ involvement (lung, sinus, skin)
Induction
Steroid +/- Mepolizumab (IL5 inhibitor)
Maintenance
Mepolizumab or azathioprine
IgA vasculitis (HSP) clinical presentation
Clinical tetrad
- Palpable purpura
- Arthritis
- Nephritis
- Abdo pain (GIT vasculitis)
NEED positive IgA staining on skin or renal biopsy
Treatment IgA vasculitis (HSP)
Self limiting
Supportive care only
No steroid or immunosuppressant (unless highly aggressive)
Cryoglobulins - what are they?
ab that precipitate in the cold
Dissolves with rewarming
Cryoglobulinemic vasculitis is associated with …
HCV
Treatment Cryoglobulinemic vasculitis
If associated with HCV –> HCV therapy +/- immunosuppression
Idiopathic –> immunosuppression (steroids +/- rituximab, plasma exchange)
How to differentiate between polyarteritis nodosa with fibromuscular dysplasia?
Fibromuscular dysplasia
- Non-inflammatory vasculopathy
- Affects renal and carotid arteries
- More proximal aneurysms rather than distal
- Imaging: renal and carotid artery beading (no intrarenal aneurysms)
- Neg inflammatory markers
- HTN, pulsatile tinnitus
- No systemic features of vasculitis
3 CTD vasculitis
RA
SLE
Sjogren’s
Treatment for CTD associated vasculitis with major organ involvement
1) SLE
2) RA
3) Sjogrens
SLE - similar to lupus nephritis (mycophenolate or cyclophosphamide)
RA - rituximab
Sjogren’s - mycophenolate or rituximab
Management of infection or drug induced vasculitis
Treat infection or withdraw causative drug
Supportive care
How does cryoglobulinemic vasculitis present?
Skin purpura with necrosis
Leukocytoclastic vasculitis (most common)
Raynaud’s
Peripheral neuropathy
MPGN
Can cause vascular obstruction in the extremities –> lose fingers and toes
Occurs with the cold
Low C4 (complement is fixed in this condition)
Diagnosis of takayasu arteritis
CT angiogram or MR angiogram
- Look for stenosis, beading
PET scan is very sensitive but $$$ so not readily available
Angiogram is gold standard but not done commonly